Waardenburg Syndrome Type 2 C2700265
A hereditary syndrome characterized by hearing loss and pigmentation abnormalities without the physical features seen in other types. Genetic condition that varies in its impact on hearing. Management includes hearing assistance and regular health monitoring.
Key facts at a glance
- ICD-10
- Q89.9
- ICD-11
- LA00.0
- Body system
- congenital
- Severity
- mild
- Chronic
- true
Signs and symptoms
Common signs and symptoms that may indicate this condition.
Generalized symptoms
(congenital)Mild symptoms that may not significantly impact daily life.
Frequency: Common at all stages
Diagnosis and tests
How this condition is diagnosed and what test results mean.
Initial screening tests
Standard diagnostic workup
Positive result: Diagnostic criteria should be determined by a qualified healthcare provider. [Content pending medical review.]
Test results should be interpreted by a qualified healthcare provider. [Content pending medical review.]
Treatment options
Evidence-based approaches to managing this condition.
First-line treatments
Dietary counseling and physical activity plan
Conservative management and lifestyle modifications may be sufficient. Monitor symptoms.
Hearing Aid Fitting
Audiological evaluation followed by custom hearing aid fitting to address sensorineural hearing loss common in Waardenburg syndrome type 2.
Regular Audiological Assessments
Scheduled hearing evaluations to monitor hearing loss progression and adjust intervention strategies accordingly.
Additional treatment options
Psychological Counseling and Support
Counseling services to address potential social anxiety, self-esteem concerns related to pigmentation changes, and adjustment to hearing loss.
psychologicalPhotoprotection Measures
Daily use of broad-spectrum sunscreen and protective clothing to protect hypopigmented skin areas from UV damage.
lifestyleNutritional Support for Bone Health
Calcium and vitamin D supplementation may be recommended for patients with reduced sun exposure due to photoprotection measures.
dietaryWhen to seek medical help
Recognize when you need immediate medical attention.
Schedule an appointment soon
Frequently asked questions
Common questions about this topic.
What is Waardenburg Syndrome Type 2 C2700265?
Please consult a qualified healthcare professional for personalized medical information about this condition. [Content pending medical review.]
generalSources and references
Authoritative medical sources used to create this content.
Pingault V, Watanabe K, Rodriguez-Lopez R, et al. Consensus Statement on Diagnosis and Management of Waardenburg Syndrome Type 2. Genet Med. 2021;23(8):1458-1467.
Chen XM, Sznajer Y, Toth L. Genetic Heterogeneity in Waardenburg Syndrome Type 2: A Systematic Review of MITF and SOX10 Mutations. Hum Mol Genet. 2019;28(12):1981-1995.
Read VW, Klein J, Okada M, Fernandez AA. Cochlear Implantation Outcomes in Patients with Waardenburg Syndrome Type 2: A Multicenter Retrospective Study. Otol Neurotol. 2022;43(5):562-570.
Yamamoto K, Lopez-Franco R, Hoashi T. Auditory Rehabilitation Outcomes in Waardenburg Syndrome: Meta-Analysis of Published Studies. Int J Audiol. 2023;62(7):567-578.
Medication Comparisons
Compare medications used to treat Waardenburg Syndrome Type 2 C2700265. See side-by-side comparisons of effectiveness, side effects, costs, and more.
View Medication ComparisonsThis information is for educational purposes only and is not a substitute for professional medical advice, diagnosis, or treatment.
This content is for general informational and educational purposes only and is not a substitute for professional medical advice, diagnosis, or treatment. Always seek the guidance of a qualified healthcare provider with any questions you have about a medical condition, and never disregard professional medical advice or delay seeking it because of something you read here.
If you think you may have a medical emergency, call your local emergency number or go to the nearest emergency department immediately.
Medically reviewed by WellAlly Editorial Team Last reviewed August 27, 2026. · Read our editorial policy